-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Evelo Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q3 2023.
- Evelo Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was -$17K, a 116% decline year-over-year.
- Evelo Biosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2023 was $905K, a 87.4% increase year-over-year.
- Evelo Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $930K, a 117% increase from 2021.
- Evelo Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $428K, a 4.65% increase from 2020.
- Evelo Biosciences, Inc. annual Income Tax Expense (Benefit) for 2020 was $409K, a 115% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)